Pfizer's drug tremelimumab and Bristol-Myers Squibb's ipilimumab are antibodies to a protein called CTLA-4 (cytotoxic T-lymphocyte antigen-4) that acts as anemergencybrake to prevent killer T cells from attacking healthy tissue.
Adaptive Cruise Control, EmergencyBrake Assist, available Blind Spot Monitoring, available Automatic High Beam Assist and an available Surround Camera System are all on the menu.